Treace Medical Concepts, Inc. (TMCI) Reports In-Line Q1 EPS

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25). Revenue for the quarter came in at $52.6 million versus the consensus estimate of $52.7 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Amprius Technologies, Inc. (AMPX) Reports In-Line Q1 EPS; offers guidance
• Nissan Motor Co Ltd. (7201:JP) (NSANY) PT Lowered to JPY300 at Bernstein SocGen Group
• UBS Upgrades Technogym SpA (TGYM:IM) (TCCHF) to Buy